PILRA as A Drug Target and Biomarker for Inflammatory Diseases

Target Name: PILRA

NCBI ID: G29992

PILRA

PILRA as A Drug Target and Biomarker for Inflammatory Diseases

PILRA (Paired Immunoglobin-Like Type 2 Receptor Alpha) as a Drug Target and Biomarker: A Promising Approach for the Treatment of Inflammatory Diseases

Abstract:

PILRA (Paired Immunoglobin-Like Type 2 Receptor Alpha) is a protein that is expressed in various tissues and cells in the human body. Its function is still not well understood, but it is known to play a role in the regulation of immune responses and inflammation. As a drug target and biomarker, PILRA has potential for the treatment of inflammatory diseases. In this article, we will discuss the current understanding of PILRA, its potential drug targeting applications, and its role as a biomarker for the diagnosis and monitoring of inflammatory diseases.

Introduction:

Inflammation is a fundamental biological response to tissue damage, infection, or injury. It is a complex process that involves various cellular and molecular interactions, including the production of pro-inflammatory cytokines and the recruitment of immune cells to the site of inflammation. Chronic inflammation can lead to a range of diseases, including autoimmune disorders, chronic obstructive pulmonary disease (COPD), and inflammatory bowel disease. The identification of potential drug targets and biomarkers for the treatment of inflammatory diseases is a promising approach to improve patient outcomes.

PILRA: A Protein Regulated in various tissues and cells

PILRA is a transmembrane protein that is expressed in various tissues and cells in the human body. It is characterized by a long extracellular domain, a short intracellular domain, and a unique N-terminus that contains a glycophosphorylated domain. PILRA is involved in the regulation of cellular processes, including cell signaling, cell adhesion, and cell migration.

Recent studies have shown that PILRA is involved in the regulation of T cell responses, a critical immune response that is critical for the prevention of infection and disease. PILRA has been shown to regulate the development and function of T cells, including the regulation of T cell receptor (TCR) signaling. PILRA has also been shown to play a role in the regulation of B cell responses, including the regulation of antibody production.

PILRA as a drug target:

PILRA has been identified as a potential drug target for the treatment of inflammatory diseases due to its involvement in the regulation of immune responses. Several studies have shown that inhibition of PILRA can suppress the production of pro-inflammatory cytokines and improve the production of anti-inflammatory cytokines. This suggests that PILRA may be a useful target for the treatment of inflammatory diseases.

One of the compounds that has been shown to inhibit PILRA is curcumin, a compound that is derived from turmeric, a common spice. Curcumin has been shown to inhibit the production of pro-inflammatory cytokines, including TNF-alpha, IL-1, and IL-6. It also appears to enhance the production of anti-inflammatory cytokines, including IL-10.

Another compound that has been shown to inhibit PILRA is resveratrol, a compound that is found in various fruits and vegetables, including red wine, grapes, and peanuts. Resveratrol has been shown to inhibit the production of pro-inflammatory cytokines and enhance the production of anti-inflammatory cytokines.

PILRA as a biomarker:

PILRA has also been shown to be a potential biomarker for the diagnosis and monitoring of inflammatory diseases. Several studies have shown that the levels of PILRA are elevated in individuals with inflammatory diseases, such as rheumatoid arthritis (RA), chronic obstructive pulmonary disease (COPD), and inflammatory bowel disease (IBD).

The levels of PILRA have also been shown to be reduced in individuals who have improved health outcomes, such as those who have been treated for inflammatory diseases. This suggests that PILRA may be a useful biomarker for the monitoring of inflammation and the effectiveness of anti-inflammatory treatments.

Conclusion:

PILRA is a protein that is involved in the regulation of various cellular processes in the human body. Its function is still not well understood, but it is known to play a role in the regulation of immune responses and inflammation. As a drug target and biomarker, PILRA has potential for the treatment of inflammatory diseases. Further studies are needed to fully understand its role and its potential as a new drug or biomarker.

Protein Name: Paired Immunoglobin Like Type 2 Receptor Alpha

Functions: Paired receptors consist of highly related activating and inhibitory receptors and are widely involved in the regulation of the immune system. PILRA is thought to act as a cellular signaling inhibitory receptor by recruiting cytoplasmic phosphatases like PTPN6/SHP-1 and PTPN11/SHP-2 via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules. Receptor for PIANP

The "PILRA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PILRA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets